🔎 Trials Near Me

Akèy › BPCO › Arizona › Phoenix

Etid klinik pou BPCO nan Phoenix, AZ

9 etid pou BPCO ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Ap rekriteFaz 2
  • DM Clinical Research - Phoenix, Phoenix
Laj 40 a 85 · Tout sèks · Mizajou Sep 30, 2026 · NCT07684820

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Ap rekriteFaz 3
  • Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114, Phoenix
Laj 40 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Ap rekrite
  • Banner University Medical Center, Phoenix
Laj 40 a 80 · Tout sèks · Mizajou Sep 17, 2026 · NCT06035120

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Ap rekriteFaz 2
  • Research Site, Phoenix
  • Research Site, Phoenix
  • Research Site, Phoenix
Laj 40 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Ap rekriteFaz 3
  • Research Site, Phoenix
  • Research Site, Phoenix
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Ap rekriteFaz 3
  • Research Site, Phoenix
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06878261

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Ap rekriteFaz 2/3
  • Pulmonary Associates, PA, Phoenix
Laj 35 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT07363694

STRIVE Post-Market Registry Study

Ap rekriteEtid obsèvasyon
  • Dignity Health St. Joseph's Hospital and Medical Center, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT04302272

Etid BPCO nan lòt vil

Lòt etid nan Phoenix

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.